Inflation And COVID Put Pressure On Europe’s Paracetamol Supply Chain
Executive Summary
Inflation, new COVID-19 waves and delayed cold and flu outbreaks are causing disruption to Europe's paracetamol supply chain. Industry is not currently concerned, but regulators, for example in France, are introducing measures to prevent this issue spreading from children's to adult forms of the drug, as well as to ibuprofen-based alternatives.
You may also be interested in...
Futura All Set For US FDA De Novo Application For Eroxon OTC ED Treatment
Futura Medical is preparing to seek approval from the FDA to launch OTC in the US its MED3000 erectile dysfunction treatment, marketed in Europe under the Eroxon brand name. After completing all the necessary studies demonstrating that the gel-based, drug-free product works as a self-care treatment for ED, Futura says it is confident that the soon to be submitted de novo medical device application will be successful and pave the way for a Q1 2023 launch.
New UK Health Secretary Wants More OTCs Available And Greater Role For Pharmacists
More medicines available without a prescription and more responsibility for community pharmacists are two of the goals set out by the UK's new Secretary of State for Health and Social Care.
Gut-Brain Axis Study On Haleon Probiotic Shows ‘Subtle’ Effects On Psychological Health
Haleon’s Puraflor probiotic when taken daily by adults was shown to alter gray matter volume and brain response patterns, according to a study published in the journal Cells.